Symbiotic Health Overview

  • Founded
  • 2013
  • Status
  • Out of Business
  • Employees
  • 7
  • Latest Deal Type
  • Out of Business

Symbiotic Health General Information


Developer of microbiome therapeutic products intended to provide treatment for C. difficile infections. The company develops an oral capsule therapeutic that cures Clostridium Difficile diarrhea by repopulating the patient with a protective microbiome, enabling patients to start their treatment quickly and result in a higher likelihood of successful treatment.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 87 Sandy Hollow Road
  • Port Washington, NY 11050
  • United States
+1 (201) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Symbiotic Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Jan-2019 00000 Completed Out of Business
3. Early Stage VC (Series A) 11-Oct-2016 00000 00000 00.000 Completed Startup
2. Accelerator/Incubator 14-Jul-2015 $50K $100K Completed Startup
1. Accelerator/Incubator 01-Jun-2015 $50K $50K Completed Startup
To view Symbiotic Health’s complete valuation and funding history, request access »

Symbiotic Health Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Symbiotic Health’s complete cap table history, request access »

Symbiotic Health Patents

Symbiotic Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200022911-A1 Stable macroemulsion for oral delivery of solubilized peptides, protein, and cellular therapeutics Abandoned 26-Apr-2016 0000000000
US-20170304374-A1 Capsule for the oral administration of biopharmaceuticals Abandoned 23-Oct-2014 0000000000 0

Symbiotic Health Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial